ISSN: 2332-0877

Journal des maladies infectieuses et de la thérapie

Accès libre

Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Saliva Pcr Testing as a Covid-19 Screening Strategy for Passengers Traveling Remote Islands

Moto Kimura1*,Junko Terada-Hirashima4 , Wataru Sugiura2 , Yosuke Shimizu3 , Yurika Tanaka1 , Yukari Uemura3 , Masahiro Ishikane5 , Yukumasa Kazuyama6 , Masato Ikeda6 , Kazuhiko Wakabayashi7 , Norio Ohmagari

Quarantine of coronavirus disease 2019 (COVID-19) in remote islands with weak medical systems is an important issue. We evaluated the usefulness of ship pre-boarding saliva polymerase chain reaction as a quarantine tool to prevent the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to Chichijima island by people headed to the island, which is far from the Japanese mainland. The infection rate on the island during the study period was 0.015% (2/13,448). Of the 8,910 individuals tested before boarding the ship during this study, 7 people tested positive by saliva PCR and one of them also tested positive by nasopharyngeal swab test. The quarantine strategy implemented in this study can be used as a reference for quarantine strategies in other remote islands with medical depopulation, where outbreaks must never occur